Financial review 2021-22

Segment contribution (£’000)

Patient care (cost after NHS income) Retail

Fundraising Property & investment Government Grants (Local authority retail grants & furlough grants for hospice & retail)

Net contribution*

Capital expenditure

Surplus / (Deficit) before depreciation and after capital expenditure 2,672 3,123

2021-22 2020-21

(4,141) (2,636) 1,416 (1,128) 5,264 5,527 248 149

132 1,286

2,919 3,197 (247) (73)

*Contribution is stated before depreciation. Figures included are revenue for the relevant area less direct costs and a share of overheads

Income was £16,379,644 for the year ended 31 March 2022, which was an 0.4% decrease on 2021 (£16,450,403). The large amounts of one-off Covid-19 related funding reduced significantly as operations returned to normal.

Retail income increased by 236% from £1,650,180 to £5,545,425, reflecting the huge decrease in retail income in 2020-21 when the shops were closed for most of the year.

Core patient services income decreased from £4,236,170 to £4,004,075. Trinity also received £363,418 restricted funding from NHSE to cover bed capacity and community support throughout the pandemic.

Fundraising income remained consistent from £6,087,489 in 2021 to £6,014,918 in 2022.

Total expenditure increased by 1.7% to £14,317,868 (2021: £14,079,076). The cost of inpatient and community and outpatient care decreased by 3.5% to £9,365,966, reflecting the vacancies in clinical teams.

The costs of the trading subsidiary increased by 12% to £4,181,218 as shops were operating for the majority of the year.

Fundraising costs increased by 34% to £750,575 as the fundraising team build back up to pre-pandemic levels (2021: £560,544).

We ended the year with a surplus of £2,061,776 (2021: £2,371,327). The table above adjusts this figure, removing the cost of depreciation and adding the cost of capital expenditure to show the cash surplus.